News
What's Going On European Pharma Giant AstraZeneca Stock On Wednesday?
27 Mar 24
Biotech, Large Cap, News, Health Care, Movers, Trading Ideas, General
AstraZeneca Announced Earlier, Truqap Plus Faslodex Approved In Japan For Patients With Advanced HR-positive Breast Cancer
27 Mar 24
News
EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings
21 Mar 24
Biotech, Health Care, Events, Exclusives, Interview
After Failed Prostate Cancer Study Merck's Keytruda Combination Therapy Flunks In Late-Stage Lung Cancer Study
21 Mar 24
Biotech, Large Cap, News, Health Care, General
Tagrisso With The Addition Of Chemotherapy Showed Favourable Trend In Overall Survival In EGFR-Mutated Advanced Lung Cancer With Further Follow Up In FLAURA2 Phase III Trial
21 Mar 24
Biotech, News, General
Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month
21 Mar 24
Biotech, Large Cap, News, Health Care, General
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
19 Mar 24
Analyst Color, Biotech, Equities, News, Health Care, Price Target, Initiation, Analyst Ratings, Movers, Trading Ideas, General
AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments
19 Mar 24
Biotech, M&A, News, Movers, General
Fusion Pharmaceuticals to be Acquired by AstraZeneca for $2B Plus Milestones in Oncology Breakthrough
19 Mar 24
M&A, News
AstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial Cancer
18 Mar 24
Biotech, Equities, Large Cap, News, Health Care, General
GRAIL Announces Novel Risk Classification Test On Its Methylation Platform To Be Used In Lung Cancer Study
18 Mar 24
Biotech, News, General
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus
14 Mar 24
Biotech, News, Health Care, Markets, General
AstraZeneca Beefs Up Its Endocrine Disease Pipeline With Amolyt Pharma Deal Worth $1.05B
14 Mar 24
Biotech, Large Cap, M&A, News, Health Care, Top Stories, General
AstraZeneca To Acquire Amolyt For Up To $1.05B
14 Mar 24
M&A, News
What's Going On With Silence Therapeutics Stock Today?
13 Mar 24
Equities, News, Markets, Movers, General
AstraZeneca Initiates Phase III Trial to Test BREZTRI's Potential In Enhancing COPD Patients' Cardiopulmonary Health
13 Mar 24
News
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
11 Mar 24
Analyst Color, Asia, Biotech, Equities, Large Cap, Macro Economic Events, Mid Cap, Broad U.S. Equity ETFs, Emerging Markets, Eurozone, Top Stories, Economics, Analyst Ratings, Tech, ETFs, General
On March 8, Insmed Received Notice Of Exercise By Astrazeneca AB Of Its Second And Final Option Under License Agreement, Dated Oct 4, 2016
11 Mar 24
Biotech, News, Contracts, General
Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029
7 Mar 24
Biotech, Government, Large Cap, News, Health Care, Markets, General
Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic
5 Mar 24
News, Politics, Top Stories, General
Press releases
Actinium Pharmaceuticals (ATNM) Spearheading the Future of Oncology with Iomab-ACT's Innovative Clinical Trial
27 Mar 24
News, Press Releases
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
26 Mar 24
News, Press Releases
ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
25 Mar 24
Press Releases
FDA Approves Vertex Pharmaceuticals (NASDAQ:VRTX) VX-407 for Phase I Study in Groundbreaking Move Against Polycystic Kidney Disease"
25 Mar 24
News, Press Releases
Actinium Pharmaceuticals Inc (NYSE:ATNM) Surges on Analyst Upgrade Amidst Radiopharma Sector Momentum
22 Mar 24
News, Press Releases
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
19 Mar 24
Press Releases
Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) launches strategic initiative focused on the manufacture of the highly sought after medical isotope Actinium-225 (Ac-225)
14 Mar 24
News, Press Releases
AstraZeneca announces initiation of THARROS – a Phase III clinical trial investigating the potential of BREZTRI to improve cardiopulmonary outcomes in people with COPD
13 Mar 24
Press Releases
MANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with FASENRA
23 Feb 24
Press Releases
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
19 Feb 24
Press Releases
TAGRISSO® (osimertinib) demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial
19 Feb 24
Press Releases
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
19 Feb 24
Press Releases
TAGRISSO® (osimertinib) with the addition of chemotherapy approved in the US for patients with EGFR-mutated advanced lung cancer
16 Feb 24
Press Releases
AstraZeneca Full year and Q4 2023 Financial Results
8 Feb 24
Press Releases
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
7 Feb 24
Press Releases
ENHERTU® Granted Priority Review in the U.S. for Patients with Metastatic HER2 Positive Solid Tumors
29 Jan 24
Press Releases
AIRSUPRA® (albuterol/budesonide) now available as the first and only FDA-approved anti-inflammatory rescue option for asthma
22 Jan 24
Press Releases
IMFINZI® (durvalumab) plus transarterial chemoembolization (TACE) and bevacizumab reduced the risk of disease progression or death by 23% vs. TACE in liver cancer eligible for embolization
19 Jan 24
Press Releases
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
8 Jan 24
Opinion, Press Releases
Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer
8 Jan 24
Press Releases